ArticleCancer research2026

EZH2 Suppression Diversifies Prostate Cancer Lineage Variant Evolution and Lacks Efficacy in Inhibiting Disease Progression.

Justine J Jacobi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.